Keeping you up to date with the latest developments
BioTrinity
Meet with us in London at BioTrinity April 23-24th. Aashna Shah will be there and keen to chat all things related to tissue based testing – Histology, IHC, IF and digital image analysis. If you think HistologiX can help progress your project, now in in the future then please do get in touch to arrange a meeting with her. Contact Us…
Read article
In Loving Memory of Andrew Lawrence
It is with heavy hearts we announce the passing of one of our beloved founders, Andrew Lawrence, who left us in the summer after a short battle with pancreatic cancer. Our thoughts are with his family during this difficult time, and we extend our deepest condolences to all who knew and loved him. Andrew was…
Read article
IHC vs IF: A Thorough Comparison for Research
Unfolding the Mystery of IHC vs IF The tale of modern medicine would be incomplete without the mention of the revolutionary tools that researchers employ in their quest to unravel the complex mechanisms of life and disease. Among these, two techniques stand out – Immunofluorescence (IF) and Immunohistochemistry (IHC). These methodologies, each with its unique…
Read article
Understanding FDA Guidelines for Toxicity Studies
In the complex journey of drug development, toxicology studies play an indispensable role. They provide vital insights into the safety profile of novel drug candidates and form a key component of regulatory submissions to bodies like the U.S. Food and Drug Administration (FDA). This blog post intends to explore the realm of toxicology studies in…
Read article
GLP Toxicology: A Crucial Framework for Advancing Drug Discovery
In the fascinating world of pharmaceutical breakthroughs, the immense value of GLP-guided toxicological analyses (GLP Tox) cannot be overstated. Toxicology, which examines the harmful effects of chemicals on living organisms, plays an essential role in the complex realm of drug discovery. GLP toxicity studies, conducted within this framework, serve as a pivotal tool for predicting…
Read article
Guide to Professional Histology Services: From Sample Preparation to Analysis
Ever wonder how we peer into the microscopic world of cells and tissues? Welcome to the fascinating realm of histology! It’s a science that’s pivotal to everything and plays a critical role in numerous scientific and medical endeavours from cutting-edge research to clinical diagnoses and drug development. But what does the journey of a tiny…
Read article
We’ve added Visiopharm AI to our Histopathology Workflow!
We're thrilled to announce that we've recently added Visiopharm to our Digital Pathology service, alongside the gold standard image analysis platform, HALO™ from Indica Labs.
Read article
Women’s History Month & British Science Week – Q&A with Rebecca Hanwell
To mark British Science Week and Women’s History Month we spoke to Rebecca Hanwell about her experiences studying science. Q: Can you tell us about your research progress since completing your MPhil research project at HistologiX? A: Since completion of the MPhil, I have tested Human papillomavirus (HPV) antibodies using immunohistochemical methods on tissue. My…
Read article
Scotland’s Life Sciences Dinner and Annual Awards 2023
We’re thrilled to announce that HistologiX will be attending the upcoming Scottish Life Sciences Awards, alongside our sister company from the Niche CRO Group, Intelligent Clinical. The Scottish Life Sciences Awards is a prestigious event that recognises the achievements and contributions of companies and individuals in the life sciences sector. It’s an honour to be…
Read article
Medilink Midlands Business Awards 2023
HistologiX is proud to announce that we will be attending the Medilink Midlands Business Awards 2023, where we have been nominated for the Partnership between Academia and Business award. The Medilink Midlands Business Awards recognises and celebrates the achievements of businesses and individuals in the healthcare and life sciences sector. The Partnership between Academia and…
Read article
FDA Tissue Cross-Reactivity Requirements: A Guide for Biologic Developers
If you’ve conducted a Tissue Cross-Reactivity (TCR) study and are planning to bring a biologic to market, chances are you’ll need approval from a regulatory body. In the United States that regulatory body is the Food and Drug Administration (FDA) and the FDA has been regulating TCR studies since 1983. History of the FDA Tissue…
Read article
A Quick Beginner’s Guide to Tissue Cross-Reactivity Studies in Biologic Development
As experts in cellular and digital pathology, we often get asked about the importance of Tissue cross-reactivity (TCR) studies especially by people new to the drug development process. These studies are an essential tool for evaluating the binding properties of biologics, in different human and non-human tissues. They form a crucial part of the regulatory…
Read article
How do I check if my monoclonal antibodies will cross-react?
The use of tissue cross-reactivity (TCR) assays is the most common method for checking for cross-reaction in monoclonal antibodies. These assays are designed to use the lock and key concept of antibody-antigen binding to test for off-target and on-target binding sites. It is important to use high-quality tissue samples and to interpret the results accurately with the help of experienced professionals to avoid potential pitfalls in the drug development process.
Read article
HistologiX and Antibody Analytics Strategic Partnership
We are thrilled to be working with Antibody Analytics to expand our offering and provide our customers with even more advanced solutions. This strategic partnership is an exciting opportunity for both companies and allows us to provide support from early discovery to clinical testing for targeted biologics.
Read article British Science Week – Q&A with Rebecca Hanwell
To mark British Science Week (5-14th March) and International Women’s Day we spoke to Rebecca Hanwell about her experiences studying science.
Read article British Science Week – Q&A with Dr Elizabeth Marsh
To mark British Science Week (5-14th March) and International Women’s Day we spoke to Dr. Elizabeth Marsh about her experiences working in science.
Read article
HPV-OPC Research Study
Human Papillomavirus (HPV) causes cervical cancer, but it is now known to cause approximately 75% of oropharyngeal carcinomas (OPCs) of the tonsil and base of the tongue.
Read article Women in Science – Q&A with Sue Smith
To mark International Day of Women and Girls in Science, we interviewed Sue Smith, Study Director and Histology Lab Manager at HistologiX, about her experiences studying and working in science. Sue shares her insights on choosing a career in science, the importance of on-the-job training and education, and advice for girls and women considering a career in science.
Read article Women in Science – Q&A with Sunita Mistry
To mark International Day of Women and Girls in Science, we interviewed Sunita Mistry, Business Development Manager at HistologiX, about her experiences studying and working in science. Sunita shares her insights on choosing a career in science, the role of hands-on experience, and how HistologiX is contributing to the fight against COVID-19.
Read article
HistologiX Showcase Expertise and Share Knowledge with New Resources Area on Website
Our Directors, Laboratory Managers, Study Directors and Research Scientists have in excess of 120 years of experience within Histology, Immunohistochemistry, Digital Pathology and Image Analysis.
Read article
COVID-19 Business Update – Lab Reopens
We would like to update our customers on our business operations following our decision to temporarily close the main HistologiX Lab from 25th March amid the COVID-19 outbreak.
Read article
Covid-19 Business Update
We would like to update our customers amid the ever-changing COVID-19 virus outbreak.
Read article
Scientific expertise – innovative culture – integrity
As a company, we want to have a clear idea of why we are doing what we do – what our reason for being is. To this end we have formulated a mission statement.
Read article COVID-19 and business continuity
We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward.
Read article
Histologix Commitment to Living Wage
Histologix Ltd has today accredited as a Living Wage Employer.
Read article
Board Certified Toxicological Pathologist to Read all Future TCR Studies
As part of our continued development of Histologix services we are pleased to announce that the reading of all future GLP-compliant therapeutic antibody cross-reactivity studies will be undertaken by a British (FRCPath), American (DiplACVP) board-certified veterinary and toxicologic histopathologist.
Read article
Medicines Discovery Catapult Collaboration
HistologiX have entered into partnership with the Medicines Discovery Catapult to enable science and boost growth within the UK and international R&D Life SCiences Industry.
Read article